EN | SE Contact us

Share price

BioInvent International AB is listed on NASDAQ OMX Stockholm (BINV)

SEK

+/- +/- Open Bid Ask High Low Volume Turnover Updated

alt

Shareprice information

alt

Subscription service

 

Presentations

Webcast Link
Interview with the CEO, Erik Penser Bank, Cancer research – Frontline, October 7, 2020 Click here
Presentation, Erik Penser Bank, Cancer research – Frontline, October 7, 2020 Click here
Interview with the CEO, Redeye, September 1, 2020 Click here
Presentation of BioInvent's second quarter report 2020, Sweden, August 27, 2020 Click here
Key Opinion Leader call with  Prof. Alexander Eggermont, July 21, 2020 Click here
Interview with the CEO, Redeye, April 15, 2020
Click here
Fight Cancer Seminar Redeye, Stockholm, Sweden, March 10, 2020
Click here
Presentation of BioInvent's fourth quarter report 2019, Sweden, February 27, 2020 Click here
Interview with Martin Welschof, CEO, Redeye, Lund, Sweden, December 18, 2019 Click here
Redeye Life Science Day 2019, Stockholm, Sweden, November 19, 2019 Click here
Oncology Forum 2019, Stockholm, Sweden, October 7, 2019 Click here
H.C. Wainwright 21st Annual Global Investment Conference, New York, USA, September 9, 2019 Click here
Interview with Martin Welschof, CEO, Pareto TV, Stockholm, Sverige, September 5, 2019 Click here
Presentation of BioInvent's Interim Report Q2-2019, Sweden, August 22, 2019 Click here
Redeye Pre-ASCO Seminar, Stockholm, Sweden, May 28, 2019 Click here
Interview with Martin Welschof, CEO, Pareto TV, Oslo, April 1, 2019 Click here
Interview with Martin Welschof, CEO, Redeye, Stockholm, April 1, 2019 Click here
Fight Cancer Seminar Redeye, Stockholm, Sweden, Januari 22, 2019. Click here

 

Title Download
Interview With The CEO, Pharmafocus, October, 2020 Download pdf (0.46 Mb)
Audiocast with teleconference Q2 2020, Sweden, August 27, 2020 Download pdf (0.57 Mb)
Key Opinion Leader Call With Prof. Alexander Eggermont, July 21, 2020 Download pdf (2.61 Mb)
Poster Presentation AACR 2020, BT 001, June 22 24, 2020 Download pdf (0.82 Mb)
Poster Presentation AACR 2020, Targeting TNFR2, June 22 24, 2020 Download pdf (2.23 Mb)
Company Presentation, May, 2020 Download pdf (1.7 Mb)
Fight Cancer Seminar Redeye, Stockholm, Sweden, March 10, 2020 Download pdf (0.52 Mb)
Bioinvent Audiocast With Teleconference Q4, Sweden, February 27, 2020 Download pdf (0.87 Mb)
Company Presentation At JP Morgan, San Francisco, USA, January 13 16, 2020 Download pdf (1.71 Mb)
Company Presentation At Cord Communication, Stockholm, Sweden, September 25, 2019 Download pdf (1.6 Mb)
Pareto Securities 10th Annual Health Care Conference, Stockholm, Sweden, 5 September, 2019 Download pdf (2.18 Mb)
International Cancer Cluster Showcase, Philapelphia, USA, June 3, 2019 Download pdf (0.44 Mb)
CEO's report at AGM for 2018, Lund, Sweden, April 25, 2019 Download pdf (1.68 Mb)
Fight Cancer Seminar Redeye, Stockholm, Sweden, January 22, 2019. Download pdf (1.08 Mb)

Investor information

Please find information in this section on our financial calendar, analysts who follow BioInvent and out largest owners.

Choose from the links to access the information.

financialcalendaricon.png

Financial calendar

analystsicon.png

Analysts

ownershipicon.png

Ownership

Corporate governance

BioInvent applies the Swedish Code of Corporate Governance ("the Code"). In addition to the Code, BioInvent also complies with applicable rules in the Swedish Companies Act, rules and recommendations ensuring from the Company's listing on NASDAQ OMX Stockholm, and good practices on the stock market.

Investor contact

Martin Welschof, CEO Tel. +46 (0)46-286 85 50

E-mail: martin.welschof@bioinvent.com

Subscription service

Email Subscription